Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) Invested Capital: 2020-2025

Historic Invested Capital for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $437.7 million.

  • Agilon Health's Invested Capital fell 3162.07% to $437.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $437.7 million, marking a year-over-year decrease of 3162.07%. This contributed to the annual value of $536.2 million for FY2024, which is 2344.39% down from last year.
  • Agilon Health's Invested Capital amounted to $437.7 million in Q3 2025, which was down 3162.07% from $540.5 million recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Invested Capital registered a high of $1.2 billion during Q2 2021, and its lowest value of -$298.2 million during Q1 2021.
  • In the last 5 years, Agilon Health's Invested Capital had a median value of $912.4 million in 2023 and averaged $812.0 million.
  • Per our database at Business Quant, Agilon Health's Invested Capital surged by 48939.97% in 2021 and then crashed by 3306.01% in 2023.
  • Quarter analysis of 5 years shows Agilon Health's Invested Capital stood at $1.1 billion in 2021, then dropped by 4.62% to $1.0 billion in 2022, then crashed by 33.06% to $700.3 million in 2023, then decreased by 23.44% to $536.2 million in 2024, then dropped by 18.37% to $437.7 million in 2025.
  • Its last three reported values are $437.7 million in Q3 2025, $540.5 million for Q2 2025, and $631.9 million during Q1 2025.